Last updated: 2026-09-16 10:31:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
electroCore, Inc. (ECOR) operates in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $9.97, with a market capitalisation of $88.00M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4.41 to $10.95. This page covers its latest market performance, valuation, price trends and company information.
$88.00M | |
$9.78 | |
$303.45 | |
$2.92 | |
$9.76 | |
84.23K | |
84.74K | |
-- | |
$10.95 | |
$4.41 | |
-- | |
-- |
electroCore, Inc. (ECOR) is trading at $9.65 in pre-market trading as of 2026-09-15 23:31:00, down 1.15% ($0.11) from the previous close of $9.76
Pre-market trading shows how investors are pricing ECOR before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, electroCore, Inc. (ECOR) moved from $9.21 to $9.97, representing a gain of 8.30% ($0.76).
The stock traded between $8.70 and $10.29 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 45.98 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 85.1%
ECOR is currently trading at $9.97, placing it 85.1% of the way from its 52-week low of $4.41 to its 52-week high of $10.95. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
| Industry | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| Employees | 83 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of electroCore, Inc. (ECOR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.